Christopher Posner - Apr 4, 2022 Form 4 Insider Report for Cara Therapeutics, Inc. (CARA)

Role: President and CEO, Director
Signature: /s/Darren DeStefano, Attorney-in-Fact
Stock symbol: CARA
Transactions as of: Apr 4, 2022
Transactions value $: -$25,416
Form type: 4
Date filed: 4/5/2022, 05:48 PM
Previous filing: Mar 1, 2022
Next filing: Nov 18, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CARA	Common Stock	Sale	-$25.4K	-2.01K	-0.99%	$12.67	201K	Apr 4, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on May 28, 2021 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units reported in the Form 4 filed with the Securities and Exchange Commission on November 3, 2021, and does not represent a discretionary trade by the Reporting Person.

Content

This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on May 28, 2021 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units reported in the Form 4 filed with the Securities and Exchange Commission on November 3, 2021, and does not represent a discretionary trade by the Reporting Person.